Company Active PRIVATE-LIMITED-GUARANT-NSC

Company profile

Genetic Alliance UK Ltd

Helping families affected by genetic, rare and undiagnosed conditions | Genetic Alliance UK

We work on issues that families and individuals with genetic conditions face. We provide information, support families and influence the services needed by these patients. Our work includes: reproductive techniques, diagnosis, medical research, healthcare and delivery, access to treatments and living and education.

CRN
05772999
Founded
2006
Age
20

Overview

Legal name
GENETIC ALLIANCE UK LTD
Region
South West England
Registered address
THE CLOCK TOWER, 5 FARLEIGH COURT OLD WESTON ROAD
FLAX BOURTON
BRISTOL
ENGLAND
BS48 1UR
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

8 events
20 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

06 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

18 Oct
2024

Accounts With Accounts Type Small

Accounts PDF pending

AA | Transaction MzQ0MDAzOTU2MWFkaXF6a2N4 | Paper/PDF filed

Published 19 Oct 2024 06:34

19 Sep
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzNjUyMzE3MmFkaXF6a2N4

Published 19 Sep 2024 11:28

19 Sep
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzNjUyMzE5N2FkaXF6a2N4

Published 19 Sep 2024 11:28

06 Apr
2006

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2024
Funded years
2024
Age at first award
18 years

Projects

2024 EU-Funded Lead participant

ERDERA

1 Sep 2024 to 31 Aug 2027

Awarded
£35,733
Total cost £35,733

The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare disease in Europe, by making Europe a world leader in Rare Disease (RD) research and innovation, to support concrete health benefits to rare disease patients, through better prevention, diagnosis and treatment. This P...

Product types

EU-Funded